Dr. Sergio Giralt of Memorial Sloan-Kettering discusses the role of transplant, how transplant side effects (including host vs. graft) are being minimized and how all roads to a cure lead through complete remission

Dr. Sergio Giralt of Memorial Sloan-Kettering discusses the role of transplant, how transplant side effects (including host vs. graft) are being minimized and how all roads to a cure lead through complete remission
Event Description
Dr. Sergio Giralt, MD Memorial Sloan-Kettering Cancer Center
Interview date: September 20, 2013
Dr. Sergio Giralt discusses the role of transplant as consolidation therapy and his current study of how the various approaches relate to a patient's cytogenetics. He shares his experience showing high-dose melphalan with an autologous transplant is still the best way of achieving long-term disease control and how the road to cure goes through complete remission. He discusses the 5 stages of transplantation and describes how he is working to use newer combinations to both improve the effectiveness of transplants but also to reduce the time to recovery and side effects for patients, with the goal to make transplantation as tolerable as regular chemotherapy. He shares studies at Memorial Sloan-Kettering that are working to eliminate host vs. graft disease for allogeneic transplant and why young, high-risk myeloma patients may want to consider that option. He describes new approaches at Memorial targeting gene mutations (like BRAF and MET gene mutations) and how a vaccine approach is just beginning. He describes the near future of genetic-specific trials that are just beginning in high-risk myeloma, but that they require national support so that one particular study can target a sufficient number of patients. He stresses the importance of patient participation in clinical trials to push forward new and better therapies in myeloma.
Schedule & Agenda
Speakers & Moderators

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org






Get the Latest B-Cell Lymphoma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.